Chattem Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHATTEM, and when can generic versions of CHATTEM drugs launch?
CHATTEM has twenty approved drugs.
There are two US patents protecting CHATTEM drugs.
There are sixty-seven patent family members on CHATTEM drugs in forty countries and two supplementary protection certificates in two countries.
Drugs and US Patents for Chattem
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chattem | UNISOM | doxylamine succinate | TABLET;ORAL | 018066-001 | Approved Prior to Jan 1, 1982 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Chattem Sanofi | ALLEGRA | fexofenadine hydrochloride | SUSPENSION;ORAL | 021963-001 | Oct 16, 2006 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Chattem Sanofi | ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION | fexofenadine hydrochloride; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021704-002 | Jan 24, 2011 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Chattem Sanofi | NICODERM CQ | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020165-004 | Aug 2, 1996 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Chattem
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chattem Sanofi | ALLEGRA | fexofenadine hydrochloride | SUSPENSION;ORAL | 021963-001 | Oct 16, 2006 | 6,399,632 | ⤷ Sign Up |
Chattem Sanofi | XYZAL | levocetirizine dihydrochloride | SOLUTION;ORAL | 022157-001 | Jan 28, 2008 | 5,698,558*PED | ⤷ Sign Up |
Chattem Sanofi | ALLEGRA | fexofenadine hydrochloride | CAPSULE;ORAL | 020625-001 | Jul 25, 1996 | 7,138,524*PED | ⤷ Sign Up |
Chattem Sanofi | CHILDREN'S ALLEGRA ALLERGY | fexofenadine hydrochloride | TABLET;ORAL | 020872-005 | Jan 24, 2011 | 5,578,610*PED | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for CHATTEM drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Oral Suspension | 30 mg/5 mL | ➤ Subscribe | 2010-01-25 |
➤ Subscribe | Oral Solution | 0.5 mg/mL | ➤ Subscribe | 2009-01-14 |
➤ Subscribe | Tablets | 150 mg | ➤ Subscribe | 2007-10-30 |
➤ Subscribe | Transdermal System | 7 mg/24 hrs, 14 mg/24 hrs, and 21 mg/24 hrs | ➤ Subscribe | 2014-05-30 |
➤ Subscribe | Tablets | 5 mg | ➤ Subscribe | 2007-12-17 |
International Patents for Chattem Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Ecuador | SP088532 | ⤷ Sign Up |
Austria | E443512 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2006005507 | ⤷ Sign Up |
Russian Federation | 2008128418 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Chattem Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0663828 | C300085 | Netherlands | ⤷ Sign Up | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
0058146 | 2001C/045 | Belgium | ⤷ Sign Up | PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.